Cancer Immunotherapy Market rise at CAGR of 13.8% to reach USD $152.83 Billion By 2024
The Global Cancer Immunotherapy Market is expected to grow at a CAGR of 13.8%
from 2018 to reach USD 152.83 billion by 2024. The high growth of cancer
immunotherapy market is attributed to factors such as rising incidence of
cancer globally, rising adoption of cancer immunotherapies over other
conventional cancer treatments owing to the increased survival rate and less
side effects with immunotherapy drugs, increasing number of ongoing clinical
trials with the help of rising investments by major players in the market, and
development of bioinformatics tools that are enhancing the drug development
process for cancer immunotherapy market. However, high cost of the cancer
immunotherapy treatment is restricting the growth of this market in emerging
countries to a certain extent.
The global cancer immunotherapy market study presents
historical market data in terms of values (2016 and 2017), estimated current
data (2018), and forecasts for 2024-by product (monoclonal antibodies,
checkpoint inhibitors, immunomodulators, vaccines, and cell therapy),
application (lung cancer, breast cancer, multiple myeloma, colorectal cancer,
melanoma, prostate cancer, and other cancer types), and end user (hospitals, and
clinics & others). The study also evaluates industry competitors and
analyzes
Table of Contents-Snapshot:
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Industry insights
6. Global Cancer Immunotherapy Market, by
Type
7. Global Cancer Immunotherapy Market, by
Application
8. Global Cancer Immunotherapy Market, by
End User
9. Cancer Immunotherapy Market, by
Geography
10. Competitive Landscape
11. Company Profiles
12. Appendix
Download free sample pdf@ https://www.meticulousresearch.com/download-sample-report/?cp_id=4690
Contact Us:
Viren Shrivastava
AVP- Global Sales and Marketing
Email: viren@meticulousresearch.com
Comments
Post a Comment